N

Nexalin Technology Inc
NASDAQ:NXL

Watchlist Manager
Nexalin Technology Inc
NASDAQ:NXL
Watchlist
Price: 0.64 USD 9.78%
Market Cap: 11.9m USD

Nexalin Technology Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nexalin Technology Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
N
Nexalin Technology Inc
NASDAQ:NXL
Operating Income
-$7.8m
CAGR 3-Years
-9%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Income
$3.5B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Operating Income
$3.8B
CAGR 3-Years
24%
CAGR 5-Years
29%
CAGR 10-Years
15%
Stryker Corp
NYSE:SYK
Operating Income
$5.4B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Operating Income
$8B
CAGR 3-Years
-6%
CAGR 5-Years
13%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.8B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
15%
No Stocks Found

Nexalin Technology Inc
Glance View

Market Cap
11.6m USD
Industry
Health Care

Nexalin Technology, Inc. designs and develops neurostimulation products. The company is headquartered in Laguna Niguel, California and currently employs 2 full-time employees. The company went IPO on 2022-09-16. The firm developed an easy-to-administer medical device, Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. The company is also designing clinical trials for the use of Gen-2 for the treatment of substance use disorders and particularly substance abuse issues related to opiates, chronic pain, Alzheimer’s disease and dementia. The firm's products are non-invasive and undetectable and can provide relief to those afflicted with mental health issues without adverse side effects. Its design of varying voltages, currents, electromagnetic fields and various frequencies called as waveform. Its devices generate a high frequency, charge balanced electrical current waveform that is applied to an array of electrodes on the head.

NXL Intrinsic Value
0.03 USD
Overvaluation 96%
Intrinsic Value
Price
N

See Also

What is Nexalin Technology Inc's Operating Income?
Operating Income
-7.8m USD

Based on the financial report for Dec 31, 2024, Nexalin Technology Inc's Operating Income amounts to -7.8m USD.

What is Nexalin Technology Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-40%

Over the last year, the Operating Income growth was -36%. The average annual Operating Income growth rates for Nexalin Technology Inc have been -9% over the past three years , -40% over the past five years .

Back to Top